Eloxx Pharmaceuticals (CE) Aktie - ELOX

Professionelle Tools für Privatanleger.

Premium

Current Price

0,0001

Gebot

0,00

Fragen

0,00

Volumen

131

0,0001 Tagesbereich 0,0001

0,000001 52-Wochen-Bereich 0,84

Marktkapitalisierung

314,339

Handelsende

0,0001

Handelsbeginn

0,0001

Letzte Trade

100

0.0001

Letzter Handelszeitpunkt

Finanzvolumen

US$ 0

VWAP

0,0001

Durchschnittliches Volumen (3 Mio.)

1.474

Ausgegebene Aktien

3.143.390

Dividendenrendite

Kurs-Gewinn-Verhältnis

0,00

Gewinn pro Aktie (EPS)

-11,47

Erlöse

Nettogewinn

-36,07M

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

www.eloxxpharma.com

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Eloxx Pharmaceuticals Inc (CE) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker ELOX. The last closing price for Eloxx Pharmaceuticals (CE) was US$0,00. Over the last year, Eloxx Pharmaceuticals (CE) shares have traded in a share price range of US$ 0,000001 to US$ 0,84.

Eloxx Pharmaceuticals (CE) currently has 3.143.390 shares in issue. The market capitalisation of Eloxx Pharmaceuticals (CE) is US$314,34 . Eloxx Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0.0001	0.0001	0.0001	200	0.0001	CS
4	0	0	0.0001	0.0401	1.0E-6	1349	9.694E-5	CS
12	9.9E-5	9900	1.0E-6	0.0401	1.0E-6	1474	7.333E-5	CS
26	0	0	0.0001	0.7501	1.0E-6	1761	0.00279433	CS
52	-0.7399	-99.9864864865	0.74	0.84	1.0E-6	4488	0.15497469	CS
156	-10.1099	-99.9990108803	10.11	10.11	1.0E-6	11121	0.98255404	CS
260	-10.1499	-99.9990147783	10.15	10.15	1.0E-6	10839	0.98255404	CS

ELOX - Frequently Asked Questions (FAQ)

What is the current Eloxx Pharmaceuticals (CE) share price?

The current share price of Eloxx Pharmaceuticals (CE) is US$ 0,0001

How many Eloxx Pharmaceuticals (CE) shares are in issue?

Eloxx Pharmaceuticals (CE) has 3.143.390 shares in issue

What is the market cap of Eloxx Pharmaceuticals (CE)?

The market capitalisation of Eloxx Pharmaceuticals (CE) is USD 314,34

What is the 1 year trading range for Eloxx Pharmaceuticals (CE) share price?

Eloxx Pharmaceuticals (CE) has traded in the range of US$ 0,000001 to US$ 0,84 during the past year

What is the reporting currency for Eloxx Pharmaceuticals (CE)?

Eloxx Pharmaceuticals (CE) reports financial results in USD

What is the latest annual profit for Eloxx Pharmaceuticals (CE)?

The latest annual profit of Eloxx Pharmaceuticals (CE) is USD -36,07M

What is the registered address of Eloxx Pharmaceuticals (CE)?

The registered address for Eloxx Pharmaceuticals (CE) is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808

What is the Eloxx Pharmaceuticals (CE) website address?

The website address for Eloxx Pharmaceuticals (CE) is www.eloxxpharma.com

Which industry sector does Eloxx Pharmaceuticals (CE) operate in?

Eloxx Pharmaceuticals (CE) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
VGFCQVery Good Food Company Inc (CE)	US$ 0,005 (499.900,00%)	259,63k
NTPLNetplex Group Inc (CE)	US$ 0,0025 (249.900,00%)	400
BIRMFBiorem Inc (PK)	US$ 1,70 (154.445,45%)	9,7k
OSKADAmpliPay Group Inc (PK)	US$ 1,10 (52.280,95%)	204
ANGCFEon Lithium Corporation (PK)	US$ 1,00 (28.471,43%)	100
TAYOTaylor Consulting Inc (CE)	US$ 0,000001 (-99,83%)	1.000
RGFCReal Good Food Company Inc (CE)	US$ 0,0001 (-99,80%)	915
BIMIBIMI International Medical Inc (CE)	US$ 0,0001 (-99,67%)	1.000
COGDFCompass Gold Corporation (PK)	US$ 0,0005 (-99,67%)	6,06k
BIOAFBioasis Technologies Inc (CE)	US$ 0,000001 (-99,50%)	2,5k
AFFUAffluence Corp (PK)	US$ 0,0002 (42,86%)	328,94M
GTCHGBT Technologies Inc (PK)	US$ 0,00025 (-16,67%)	279,95M
PSWWPrincipal Solar Inc (PK)	US$ 0,0005 (25,00%)	208,44M
HMBLHUMBL Inc (PK)	US$ 0,0003 (20,00%)	173,92M
DPLSDarkPulse Inc (PK)	US$ 0,0004 (14,29%)	135,91M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Eloxx Pharmaceuticals Inc (CE) (ELOX)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Eloxx Pharmaceuticals Inc (CE)

ELOX Neueste Nachrichten

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 4 - Statement of changes in beneficial ownership of securities

ELOX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Eloxx Pharmaceuticals Inc (CE) (ELOX) Börsenkurse

Eloxx Pharmaceuticals Inc (CE) (ELOX)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Eloxx Pharmaceuticals Inc (CE)

ELOX Neueste Nachrichten

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 4 - Statement of changes in beneficial ownership of securities

ELOX - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen